With the exception of HBV, all the common viruses
that cause hepatitis are known as RNA viruses because they contain
ribonucleic acid or RNA as their genetic material. HBV is the only
deoxyribonucleic acid or DNA virus that is a major cause of
hepatitis. HBV is made up of several fragments, called antigens,
that stimulate the body's immune system to produce the antibodies
that can neutralize or even destroy the infecting virus. It is, in
fact, the immune reaction, not the virus, that seems to cause the
liver inflammation.
Acute hepatitis B
In the United States, a majority of acute HBV
infections occur in teenagers and young adults. Half of these youth
never develop symptoms, and only about 20%-or one in five infected
patients-develop severe symptoms and yellowing of the skin (jaundice).
Jaundice occurs when the infected liver is unable to get rid of
certain colored substances, or pigments, as it normally does. The
remaining 30% of patients have only "flu-like" symptoms and will
probably not even be diagnosed as having hepatitis unless certain
tests are done.
The commonest symptoms of acute hepatitis B are
loss of appetite, nausea, generally feeling poorly, and pain or
tenderness in the right upper part of the abdomen (where the liver
is located). Compared to patients with hepatitis A or C, those with
HBV infection are less able to continue their usual activities and
require more time resting in bed.
Occasionally patients with HBV infection will
develop joint swelling and pain (arthritis) as well as hives or a
skin rash before jaundice appears. The joint symptoms usually last
no longer than three to seven days.
Typically the symptoms of acute hepatitis B do
not persist longer than two or three months. If they continue for
four months, the patient has an abnormally long-lasting acute
infection. In a small number of patients-probably fewer than 3%--the
infection keeps getting worse as the liver cells die off. Jaundice
deepens, and patients may bleed easily when the levels of
coagulation factors (normally made by the liver) decrease. Large
amounts of fluid collect in the abdomen and beneath the skin
(edema). The least common outcome of acute HBV infection, seen in
fewer than 1% of patients, is fulminant hepatitis, when the liver
fails entirely. Only about half of these patients can be expected to
live.
Chronic hepatitis B
HBV infection lasting longer than six months is
said to be chronic. After this time it is much less likely for the
infection to disappear. Not all carriers of the virus develop
chronic liver disease; in fact, a majority have no symptoms. But,
about one in every four HBV carriers do develop liver disease which
gets worse over time, as the liver becomes more and more scarred and
less able to carry out its normal functions. A badly scarred liver
is called cirrhosis. Patients are likely to have an enlarged liver
and spleen, as well as tiny clusters of abnormal blood vessels in
the skin that resemble spiders.
The most serious complication of chronic HBV
infection is liver cancer. Worldwide this is the commonest cancer to
occur in men. Nevertheless, the overall chance that liver cancer
will develop at any time in a patient's life is probably much lower
than 10%. Patients with chronic hepatitis B who drink or smoke are
more likely to develop liver cancer. It is not unusual for a person
to simultaneously have both HBV infection and infection by HIV
(human immunodeficiency virus, the cause of AIDS).